FUNIOTCServices-Testing LaboratoriesFiscal year ends September 30
Hypha Labs, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.00−0.00 (-4.55%)
Close on Oct 19, 2026
- Market cap
- $688.36K
- P/E (TTM)
- –
- Dividend yield
- –
Hypha Labs, Inc. revenue by segment
By business segment
| Revenue | FY2015 | FY2014 | FY2013 | % of revenue | YoY |
|---|---|---|---|---|---|
| Microscopy [Member] | $395.72K | $485.87K | – | 2460.3% | -18.6% |
| Cannabis [Member] | $16.08K | – | – | 100.0% | – |
| Operating income | FY2015 | FY2014 | FY2013 | YoY |
|---|---|---|---|---|
| Microscopy [Member] | -$618.94K | -$496.67K | – | +24.6% |
| Cannabis [Member] | -$3.44M | -$2.32M | – | +48.1% |
By product or service
By region
| Revenue | FY2015 | FY2014 | FY2013 | % of revenue | YoY |
|---|---|---|---|---|---|
| Cannabis [Member] | – | $0 | $0 | – | – |
| Microscopy [Member] | – | $485.87K | $567.19K | – | – |
From the segment and revenue-disaggregation notes of Hypha Labs's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.